Modelling the population-level benefits and cost-effectiveness of cell-based quadrivalent influenza vaccine for children and adolescents aged 6 months to 17 years in the US
Background Cell-based quadrivalent influenza vaccines (QIVc) can increase effectiveness against seasonal influenza by avoiding mismatch from egg adaption of vaccine viruses. This study evaluates the population-level cost-effectiveness and impacts on health outcomes of QIVc versus an egg-based vaccin...
Sparad:
| Huvudupphovsmän: | , , |
|---|---|
| Materialtyp: | Artikel |
| Språk: | engelska |
| Publicerad: |
Taylor & Francis Group
2024-12-01
|
| Serie: | Expert Review of Vaccines |
| Ämnen: | |
| Länkar: | https://www.tandfonline.com/doi/10.1080/14760584.2023.2295014 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|